Medical - Instruments & Supplies
Compare Stocks
2 / 10Stock Comparison
DXR vs TFX
Revenue, margins, valuation, and 5-year total return — side by side.
Medical - Instruments & Supplies
DXR vs TFX — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||
|---|---|---|
| Industry | Medical - Instruments & Supplies | Medical - Instruments & Supplies |
| Market Cap | $59M | $5.45B |
| Revenue (TTM) | $868K | $2.96B |
| Net Income (TTM) | $3M | $-906M |
| Gross Margin | 91.4% | 53.3% |
| Operating Margin | 5.4% | 9.7% |
| Forward P/E | 92.2x | 18.3x |
| Total Debt | $730K | $2.73B |
| Cash & Equiv. | — | $393M |
DXR vs TFX — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Daxor Corporation (DXR) | 100 | 76.1 | -23.9% |
| Teleflex Incorporat… (TFX) | 100 | 34.0 | -66.0% |
Price return only. Dividends and distributions are not included.
Quick Verdict: DXR vs TFX
Each card shows where this stock fits in a portfolio — not just who wins on paper.
DXR carries the broadest edge in this set and is the clearest fit for income & stability and long-term compounding.
- Dividend streak 0 yrs, beta 0.33
- 27.9% 10Y total return vs TFX's -15.1%
- Lower volatility, beta 0.33, Low D/E 2.0%, current ratio 0.17x
TFX is the clearest fit if your priority is growth exposure.
- Rev growth -34.6%, EPS growth -14.7%, 3Y rev CAGR -10.6%
- -34.6% revenue growth vs DXR's -93.8%
- Lower P/E (18.3x vs 92.2x)
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | -34.6% revenue growth vs DXR's -93.8% | |
| Value | Lower P/E (18.3x vs 92.2x) | |
| Quality / Margins | 401.5% margin vs TFX's -30.6% | |
| Stability / Safety | Beta 0.33 vs TFX's 1.06, lower leverage | |
| Dividends | 1.1% yield; the other pay no meaningful dividend | |
| Momentum (1Y) | +33.8% vs TFX's +3.3% | |
| Efficiency (ROA) | 9.8% ROA vs TFX's -12.3%, ROIC 1.3% vs 3.4% |
DXR vs TFX — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
DXR vs TFX — Financial Metrics
Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.
Income & Cash Flow (Last 12 Months)
DXR leads this category, winning 4 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
TFX is the larger business by revenue, generating $3.0B annually — 3414.8x DXR's $867,859. DXR is the more profitable business, keeping 4.0% of every revenue dollar as net income compared to TFX's -30.6%. On growth, TFX holds the edge at -28.5% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | ||
|---|---|---|
| RevenueTrailing 12 months | $867,859 | $3.0B |
| EBITDAEarnings before interest/tax | $7M | $478M |
| Net IncomeAfter-tax profit | $3M | -$906M |
| Free Cash FlowCash after capex | -$5M | $245M |
| Gross MarginGross profit ÷ Revenue | +91.4% | +53.3% |
| Operating MarginEBIT ÷ Revenue | +5.4% | +9.7% |
| Net MarginNet income ÷ Revenue | +4.0% | -30.6% |
| FCF MarginFCF ÷ Revenue | -5.4% | +8.3% |
| Rev. Growth (YoY)Latest quarter vs prior year | -74.4% | -28.5% |
| EPS Growth (YoY)Latest quarter vs prior year | +78.2% | -4.5% |
Valuation Metrics
TFX leads this category, winning 4 of 5 comparable metrics.
Valuation Metrics
On an enterprise value basis, TFX's 18.0x EV/EBITDA is more attractive than DXR's 29.1x.
| Metric | ||
|---|---|---|
| Market CapShares × price | $59M | $5.5B |
| Enterprise ValueMkt cap + debt − cash | $60M | $7.8B |
| Trailing P/EPrice ÷ TTM EPS | 92.18x | -6.09x |
| Forward P/EPrice ÷ next-FY EPS est. | — | 18.34x |
| PEG RatioP/E ÷ EPS growth rate | — | — |
| EV / EBITDAEnterprise value multiple | 29.06x | 17.96x |
| Price / SalesMarket cap ÷ Revenue | 27.73x | 2.74x |
| Price / BookPrice ÷ Book value/share | 1.37x | 1.76x |
| Price / FCFMarket cap ÷ FCF | 2299.86x | 22.22x |
Profitability & Efficiency
DXR leads this category, winning 5 of 8 comparable metrics.
Profitability & Efficiency
DXR delivers a 10.1% return on equity — every $100 of shareholder capital generates $10 in annual profit, vs $-24 for TFX. DXR carries lower financial leverage with a 0.02x debt-to-equity ratio, signaling a more conservative balance sheet compared to TFX's 0.87x.
| Metric | ||
|---|---|---|
| ROE (TTM)Return on equity | +10.1% | -23.7% |
| ROA (TTM)Return on assets | +9.8% | -12.3% |
| ROICReturn on invested capital | +1.3% | +3.4% |
| ROCEReturn on capital employed | +1.7% | +4.0% |
| Piotroski ScoreFundamental quality 0–9 | 5 | 5 |
| Debt / EquityFinancial leverage | 0.02x | 0.87x |
| Net DebtTotal debt minus cash | $729,966 | $2.3B |
| Cash & Equiv.Liquid assets | — | $393M |
| Total DebtShort + long-term debt | $729,966 | $2.7B |
| Interest CoverageEBIT ÷ Interest expense | -6.11x | -0.95x |
Total Returns (Dividends Reinvested)
DXR leads this category, winning 5 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in DXR five years ago would be worth $10,769 today (with dividends reinvested), compared to $3,191 for TFX. Over the past 12 months, DXR leads with a +33.8% total return vs TFX's +3.3%. The 3-year compound annual growth rate (CAGR) favors DXR at -4.8% vs TFX's -21.1% — a key indicator of consistent wealth creation.
| Metric | ||
|---|---|---|
| YTD ReturnYear-to-date | -29.4% | +1.0% |
| 1-Year ReturnPast 12 months | +33.8% | +3.3% |
| 3-Year ReturnCumulative with dividends | -13.7% | -50.9% |
| 5-Year ReturnCumulative with dividends | +7.7% | -68.1% |
| 10-Year ReturnCumulative with dividends | +27.9% | -15.1% |
| CAGR (3Y)Annualised 3-year return | -4.8% | -21.1% |
Risk & Volatility
Evenly matched — DXR and TFX each lead in 1 of 2 comparable metrics.
Risk & Volatility
DXR is the less volatile stock with a 0.33 beta — it tends to amplify market swings less than TFX's 1.06 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. TFX currently trades 88.3% from its 52-week high vs DXR's 68.7% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.33x | 1.06x |
| 52-Week HighHighest price in past year | $14.76 | $139.63 |
| 52-Week LowLowest price in past year | $7.10 | $100.18 |
| % of 52W HighCurrent price vs 52-week peak | +68.7% | +88.3% |
| RSI (14)Momentum oscillator 0–100 | 55.6 | 44.9 |
| Avg Volume (50D)Average daily shares traded | 11K | 875K |
Analyst Outlook
Insufficient data to determine a leader in this category.
Analyst Outlook
TFX is the only dividend payer here at 1.09% yield — a key consideration for income-focused portfolios.
| Metric | ||
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | — | Buy |
| Price TargetConsensus 12-month target | — | $132.20 |
| # AnalystsCovering analysts | — | 29 |
| Dividend YieldAnnual dividend ÷ price | — | +1.1% |
| Dividend StreakConsecutive years of raises | 0 | 0 |
| Dividend / ShareAnnual DPS | — | $1.35 |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | +5.5% |
DXR leads in 3 of 6 categories (Income & Cash Flow, Profitability & Efficiency). TFX leads in 1 (Valuation Metrics). 1 tied.
DXR vs TFX: Frequently Asked Questions
8 questions · data-driven answers · updated daily
01Is DXR or TFX a better buy right now?
For growth investors, Teleflex Incorporated (TFX) is the stronger pick with -34.
6% revenue growth year-over-year, versus -93. 8% for Daxor Corporation (DXR). Daxor Corporation (DXR) offers the better valuation at 92. 2x trailing P/E, making it the more compelling value choice. Analysts rate Teleflex Incorporated (TFX) a "Buy" — based on 29 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which is the better long-term investment — DXR or TFX?
Over the past 5 years, Daxor Corporation (DXR) delivered a total return of +7.
7%, compared to -68. 1% for Teleflex Incorporated (TFX). Over 10 years, the gap is even starker: DXR returned +27. 9% versus TFX's -15. 1%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
03Which is safer — DXR or TFX?
By beta (market sensitivity over 5 years), Daxor Corporation (DXR) is the lower-risk stock at 0.
33β versus Teleflex Incorporated's 1. 06β — meaning TFX is approximately 222% more volatile than DXR relative to the S&P 500. On balance sheet safety, Daxor Corporation (DXR) carries a lower debt/equity ratio of 2% versus 87% for Teleflex Incorporated — giving it more financial flexibility in a downturn.
04Which is growing faster — DXR or TFX?
By revenue growth (latest reported year), Teleflex Incorporated (TFX) is pulling ahead at -34.
6% versus -93. 8% for Daxor Corporation (DXR). On earnings-per-share growth, the picture is similar: Daxor Corporation grew EPS 81. 5% year-over-year, compared to -1468. 2% for Teleflex Incorporated. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
05Which has better profit margins — DXR or TFX?
Daxor Corporation (DXR) is the more profitable company, earning 25.
2% net margin versus -45. 4% for Teleflex Incorporated — meaning it keeps 25. 2% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: DXR leads at 29. 2% versus 12. 8% for TFX. At the gross margin level — before operating expenses — DXR leads at 100. 0%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
06Which pays a better dividend — DXR or TFX?
In this comparison, TFX (1.
1% yield) pays a dividend. DXR does not pay a meaningful dividend and should not be held primarily for income.
07Is DXR or TFX better for a retirement portfolio?
For long-horizon retirement investors, Daxor Corporation (DXR) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.
33)). Both have compounded well over 10 years (DXR: +27. 9%, TFX: -15. 1%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
08What are the main differences between DXR and TFX?
Both stocks operate in the Healthcare sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
TFX pays a dividend while DXR does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.